Kazia Therapeutics Limited American Depositary Shares vs. Eli Lilly & Co.
KZIA
Kazia Therapeutics Limited American Depositary Shares
$13.58 -19.64%
VS LLYEli Lilly & Co.
$1174.61 -0.13%
Kazia Therapeutics Limited American Depositary Shares and Eli Lilly & Co. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| KZIA | LLY | |
|---|---|---|
| Market Cap | $155.18 million | $1.05 trillion |
| Revenue (TTM) | — | $79.67 billion |
| Net Income (TTM) | — | $26.71 billion |
LLY leads on 1 of 1 size & scale factors.
Valuation
| KZIA | LLY | |
|---|---|---|
| P/E Ratio | — | 39.43 |
| Price / Book | — | 30.90 |
| Price / Sales | — | 13.14 |
KZIA and LLY split the valuation factors evenly.
Profitability
| KZIA | LLY | |
|---|---|---|
| Net Margin | — | 33.53% |
| Return on Equity | — | 78.84% |
KZIA and LLY split the profitability factors evenly.
Dividend
| KZIA | LLY | |
|---|---|---|
| Dividend Yield | — | 0.59% |
| Payout Ratio | — | 23.23 |
KZIA and LLY split the dividend factors evenly.
Risk & Sentiment
| KZIA | LLY | |
|---|---|---|
| Short Interest | 0.04% | 1.29% |
KZIA leads on 1 of 1 risk & sentiment factors.
Dig deeper: KZIA overview, KZIA financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.